グリクラジドの中国市場

調査会社China Research and Intelligence社が発行したリサーチレポート(データ管理コード:DATA8102365)
◆英語タイトル:Investigation Report on China's Gliclazide Market, 2018-2022
◆発行会社/調査会社:China Research and Intelligence
◆商品コード:DATA8102365
◆発行日:2018年9月
◆調査対象地域:中国
◆産業分野:製薬
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,200 ⇒換算¥239,800見積依頼/購入/質問フォーム
EnterprisewideUSD3,300 ⇒換算¥359,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
China Research and Intelligence社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[グリクラジドの中国市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DescriptionThe overweight population and the incidence of type 2 diabetes are growing in China as the economy develops, the population ages, and the lifestyle changes. The number of people with type 2 diabetes exceeded 110 million at the end of 2017, and is still rising.
Taken by mouth, Gliclazide is a second-generation sulfonylurea to treat diabetes by stimulating insulin secretion from pancreatic β-cells. It can protect pancreatic β-cells from the apoptosis caused by hyperglycemia, and prevent atherosclerosis (build-up of fatty deposits in the arteries) caused by type 2 diabetes.
Developed by French company Servier, Gliclazide (trade name: Diamicron) was first launched in France in 1972, and entered China in the 1980s. In China, at least 200,000 people with type 2 diabetes are taking Gliclazide every year.
In 1987, Tianjin Huajin Pharmaceutical Factory (now known as Tianjin Huajin Pharmaceutical Co., Ltd.) started cooperating with Servier and Tianjin Pharmaceutical Station to produce Gliclazide (Diamicron), a new drug to treat type 2 diabetes. With the support of Servier, the company has been taking the leading position on China’s Gliclazide market. Also dominating the market are Servier and Servier (Tianjin) Pharmaceutical Co., Ltd., the joint venture of Servier and Tianjin Huajin Pharmaceutical Co., Ltd.
According to CRI, the sales value of Gliclazide kept rising after the drug entered China, and exceeded CNY 200 million in 2017. It is expected that China’s Gliclazide market will continue to grow as the incidence of type 2 diabetes rises.

*** レポート目次(コンテンツ)***

Table of Contents
1 Relevant Concepts of Gliclazide
1.1 Indications for Gliclazide
1.2 Development History of Gliclazide in China
1.3 Governmental Approval of Gliclazide in China

2 Sales of Gliclazide in China, 2013-2017
2.1 Sales Value
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Gliclazide by Dosage Form in China, 2013-2017
2.3.1 Tablets
2.3.2 Capsules

3 Analysis on Major Gliclazide Manufacturers in China, 2013-2017
3.1 Analysis on Market Share of Major Gliclazide Manufacturers
3.1.1 Market Share by Sales Value
3.1.2 Market Share by Sales Volume
3.2 Servier
3.2.1 Enterprise Profile
3.2.2 Sales of Servier’s Gliclazide in China
3.3 Servier (Tianjin) Pharmaceutical Co., Ltd.
3.4 Tianjin Huajin Pharmaceutical Co. Ltd.
3.5 Nanchang Helioeast Pharmaceutical Co., Ltd.
3.6 Guilin Hwasun Pharmaceutical Co., Ltd.

4 Prices of Gliclazide in China, 2017-2018
4.1 Servier (Diamicron)
4.2 Servier (Tianjin) Pharmaceutical Co., Ltd. (Diamicron)
4.3 Tianjin Huajin Pharmaceutical Co. Ltd. (Diamicron)
4.4 Nanchang Helioeast Pharmaceutical Co., Ltd. (Hongxuyang)
4.5 Guilin Hwasun Pharmaceutical Co., Ltd. (Xieerping)

5 Prospect of China’s Gliclazide Market, 2018-2022
5.1 Forecast on Market Size
5.2 Forecast on Market Trend

Selected Charts
Chart Sales of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide in Parts of China, 2013-2017
Chart Sales Volume of Gliclazide in China, 2013-2017
Chart Sales Value of Gliclazide Tablets in China, 2013-2017
Chart Sales Value of Gliclazide Capsules in China, 2013-2017
Chart Market Share of Top 5 Gliclazide Manufacturers by Sales Value in China, 2013-2017
Chart Profile of Servier
Chart Sales Value of Servier’s Gliclazide in China, 2013-2017
Chart Sales Value of Servier (Tianjin) Pharmaceutical Co., Ltd.’s Gliclazide in China, 2013-2017
Chart Sales Value of Servier Tianjin Huajin Pharmaceutical Co. Ltd.’s Gliclazide in China, 2013-2017
Chart Prices of Servier’s Gliclazide in Parts of China, 2017-2018
Chart Prices of Servier (Tianjin) Pharmaceutical Co., Ltd.’s Gliclazide in Parts of China, 2017-2018
Chart Prices of Tianjin Huajin Pharmaceutical Co. Ltd.’s Gliclazide in Parts of China, 2017-2018
Chart Governmental Approval of Gliclazide in China
Chart Forecast on Sales Value of Gliclazide in China, 2018-2012



*** レポートのキーワード ***

グリクラジド

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界のマグネシウム及びマグネシウム合金市場2015
    The Global Magnesium & Magnesium Alloy Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Magnesium & Magnesium Alloy industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry ch …
  • 世界のセメント市場2017
    Notes:Sales, means the sales volume of Cement Revenue, means the sales value of Cement This report studies sales (consumption) of Cement in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market sh …
  • 酸化ビスマス・アルミニウム水和物の世界市場2018
    Bismuth Aluminum Oxide Hydrate Report by Material, Application, and Geography – Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United …
  • 気管支炎(Bronchitis):治療薬市場2018(世界市場規模、APIメーカー、市販薬、フェーズ3治験薬)
    SUMMARY DelveInsight’s Report, “Bronchitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2018”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Bronchitis Report is …
  • インドの真空掃除機市場(~2020)
    The report titled 'India Vacuum Cleaner Market Outlook to 2020 - Driven by Increasing Investment in Real Estate Sector and Facility Management Cleaning Services' provides a comprehensive analysis of the market size of India Vacuum Cleaner Market, Residential Vacuum Cleaner market, Non- Residential V …
  • 胸部画像診断技術の世界市場:マンモグラフィー(デジタル、3D)、MBI、PET-CT、CBCT、PEM、胸部MRI、胸部超音波、AWBU、胸部サーモグラフィー、光学画像
    On the basis of type, the global breast imaging market is segmented into two major categories, namely, ionizing technologies and non-ionizing technologies. Ionizing technologies are further segmented into eight subsegments, namely, analog mammography, full-field digital mammography (FFDM), 3D breast …
  • 世界の血液脂質検出器市場2017
    Blood Lipids Detector Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United S …
  • 世界及び中国のトリエチレングリコール(TEG)市場2016
    The 'Global and Chinese Tri-Ethylene Glycol (TEG) Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global Tri-Ethylene Glycol (TEG) industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tri-E …
  • 創傷治療用装置の世界市場2019-2023
    124 pages, November 2018 About this market With the recent advances in wound therapy devices, the number of indications that can be treated using these devices has expanded. For instance, the development of smaller, single-use disposable pumps have allowed the treatment of many small, surgical wound …
  • (E,E)-2,4-ヘキサジエナールの世界市場2019
    (E,E)-2,4-Hexadienal (CAS 142-83-6) Market Research Report 2019 aims at providing comprehensive data on (E,E)-2,4-Hexadienal market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes (E,E)-2,4-Hexadienal description, covers its application areas, manufactur …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DATA8102365 )"グリクラジドの中国市場" (英文:Investigation Report on China's Gliclazide Market, 2018-2022)はChina Research and Intelligence社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。